Oxidative stress in the brain is a known contributor to the development of neurodegenerative diseases, including Alzheimer’s. The focus of this project is to target the amyloid-β plaque formations and reactive oxygen species (ROS) derived from mis-regulated metal-ions that lead to disease-causing oxidative stress. The present investigation measures both the antioxidant reactivity and metal chelating ability of 1,4,11,13-tetra-aza-bis(2,6-pyridinophane)-8,17-ol (L4).  L4 contains two radical scavenging pyridol groups along with a metal-binding nitrogen rich ligand system.  It was hypothesized that increasing the number of pyridol groups on the ligands in our small molecule library would increase the radical scavenging activity, which in turn may provide cells protection from oxidative stress.  The radical scavenging ability of L4 was quantified using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical assay. This was compared to other radical scavenging small molecules to evaluate the effect of the additional radical scavenging group on the antioxidant activity.  The interaction of L4 with redox active metal-ions such as copper(II) was also evaluated using the coumarin-3-carboxylic acid (CCA) assay to show the molecule’s ability to target mis-regulated metal-ions in diseased tissues. With the end goal being to develop a potential biological therapeutic agent, metabolic stability studies were also performed.

The combination of inorganic porous silicon (pSi) and flexible biocompatible polymers has been shown to yield more beneficial hybrid scaffolds for tissue engineering (i.e. use of synthetic materials to facilitate healing). PSi has a variety of tunable properties, including pore size, pore volume and non-toxic degradation. The addition of a biocompatible polymer such as polycaprolactone (PCL) can provide control over shape and serve as an additional drug delivery component.
In this work, composite materials consisting of oxidized porous silicon (ox-pSi) with a particle size of ~ 30 μm and pore size of 40-100 nm and PCL porous fibers. Porous fibers were fabricated using an electrospinning method into sheets of desired thickness (0.1-0.4 mm), fiber diameter 3-4 μm, and fiber pore size 300-500 nm. Ox-pSi particles previously loaded with the anticancer drug-camptothecin (CPT) were placed between two sheets (6 mm in diameter each) and sealed at the edges, resulting in ~65% loading of ox-pSi. Drug release from the ox-pSi particles alone and ox-pSi/porous PCL fiber composites was monitored fluorometrically in phosphate buffered saline (PBS), showing a distinct release profile for each material.
Ox-pSi/p-PCL fiber composites release a CPT payload in accordance with the Higuchi release model and showed a significant decrease in burst effect compared to ox-pSi particles only. In addition, composite evolution after 5 weeks in PBS at 37 oC was examined using gravimetry, differential scanning calorimetry (DSC), and field emission scanning electron microscopy (FESEM). Overall weight loss of the composites was about 50%, mainly attributed to pSi particles dissolution and some polymer hydrolysis. Preliminary DSC results show that high surface area porous PCL fibers are less crystalline compared to solid PCL fibers, suggesting a faster hydrolysis route.

Europium contrast agents have been extensively investigated as an alternative to typical Gd3+ species for imaging. This is due to the dual imaging modalities which can accessed dependent on the oxidation state of the europium metal center (T1 or PARACEST). To achieve these functionalities, the europium containing complex must be stable enough to support both oxidation states (+3 and +2). In collaboration with UTSW, an electrochemical investigation was completed to understand the effects of the ligand environment on the metal center as a direct result of glycine modification to the ligand scaffold, DOTA. Increasing amide functionalities in close proximity to the europium core result in a positive shift in the potential in comparison to the acetate arms associated with DOTA. Furthermore, the addition of the glycine moiety to the pendant arms results in redox activity of the ligand itself, making the ligand non-innocent in nature. Additionally, a crystal structure of Eu4 (the tetraglycinate DOTA derivative) was obtained and compared to known lanthanide complexes.

Non-conventional solvents, such as room-temperature ionic liquids and deep-eutectic solvents, have attracted a lot of attention in recent years due their diverse applications in various areas of sciences, medicine and engineering. The ability to control physical properties of these solvents by simply adjusting their structure and/or the ratio of the components favorably distinguishes ionic and eutectic solvents from traditionally used molecular solvents as it allows to custom design specific types of media for given applications.

This presentation will highlight our efforts on various aspects of the synthesis of ionic liquids and deep-eutectic solvents as well as it will describe our investigations on the physical properties and nanostructural organization of these liquids using environmental probes, such as those that feature BODIPY and aza-BODIPY motifs. In addition, our initial studies on the design of multiphase systems that utilize ionic, eutectic and molecular solvents will be presented.

Cerium (IV) oxide, or CeO2, nanomaterials have displayed antioxidant and enzyme mimetic activities due to a Ce3+/Ce4+ redox capability enhanced through oxygen vacancies and mobility. Tri-valent, fluorescent ions such as Eu3+ increase the Ce3+/Ce4+ ratio and oxygen vacancy concentration, while contributing fluorescent properties to the nanomaterial. The combination of these attributes make europium doped cerium oxide (EuCeO¬2) nanomaterials appealing candidates for various biological applications.
To complement our earlier efforts on the synthesis and properties of EuCeO2 nanowires, nanorods, and nanocubes, this presentation addresses a new, complementary structure, EuCeO2 nanotubes. The nanotubes are prepared via deposition and subsequent oxidation of Eu-doped Ce(OH)3 to form a EuCeO2 shell on sacrificial ZnO nanowires.
Previous synthetic routes to CeO2 nanotubes have been reported featuring carbon nanotubes as sacrificial templates, the etching of cerium-based nanorods, and other less-common methods . These routes have struggled with clear evidence for distinct nanotube formation, as well as control over nanotube dimensions. Our use of a ZnO core allows for facile manipulation of inner diameter and length of the nanotube following etching of the core.
The synthesized nanotubes were characterized using scanning and transmission microscopy (SEM and TEM) for morphology, energy dispersive x-ray (EDX) for elemental composition, and photoluminescence to track europium fluorescence. Synthesized nanotubes had inner diameters from 40 nm to 200 nm, based on the ZnO core. Following synthesis and characterization, the nanotubes will be tested for use as a drug delivery vector, using ibuprofen as a model.